Mayne to Market Paxene® in the EU
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 46 (Table of Contents)
Published: 4 Apr-2004
DOI: 10.3833/pdr.v2004.i46.820 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Mayne and IVAX entered into distribution agreement to market and distribute IVAX’s injectable cancer treatment, Paxene® in the European Union companies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS